FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-034 | 71506-034-05 | Succinylcholine Chloride | Succinylcholine Chloride | 100 mg/5 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-079 | 71506-079-56 | Thiamine Hydrochloride | Thiamine Hydrochloride | 500 mg/100 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.75 g/500 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-037 | 71506-037-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1 g/250 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-014 | 71506-014-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 750 mg/250 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-045 | 71506-045-59 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.5 g/500 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-019 | 71506-019-59 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 2 g/500 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-018 | 71506-018-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1 g/250 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-015 | 71506-015-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.25 g/250 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-039 | 71506-039-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.25 g/250 mL | 2025-1 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-016 | 71506-016-59 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.5 g/500 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-174 | 63037-174-25 | Phenylephrine Hydrochloride | .5 mg/5 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-173 | 63037-173-25 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-155 | 63037-155-25 | Rocuronium Bromide | 50 mg/5 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-156 | 63037-156-25 | Rocuronium Bromide | 100 mg/10 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-119 | 63037-119-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-117 | 63037-117-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-123 | 63037-123-25 | Ephedrine Sulfate | 50 mg/5 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 50 mg/1 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 50 mg/5 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 100 mg/5 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 5 mg/5 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Injectables USA Inc. | 63037-119 | 63037-119-05 | Diltiazem HCl | Diltiazem HCl | 125 mg/125 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-117 | 63037-117-05 | Diltiazem HCl | Diltiazem HCl | 125 mg/125 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-123 | 63037-123-25 | Ephedrine Sulfate | Ephedrine Sulfate | 50 mg/5 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-100 | 63037-100-05 | Fentanyl Citrate in 0.9 % Sodium Chloride | Fentanyl Citrate in 0.9% Sodium Chloride Injection | 1000 ug/100 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-101 | 63037-101-05 | Fentanyl Citrate in 0.9% Sodium Chloride | Fentanyl Citrate in 0.9% Sodium Chloride Injection | 2500 ug/250 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-137 | 63037-137-25 | Ketamine HCl | Ketamine HCl | 50 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-136 | 63037-136-25 | Ketamine HCl | Ketamine HCl | 50 mg/5 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-164 | 63037-164-25 | Lidocaine HCl | Lidocaine HCl 2% | 100 mg/5 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 5 mg/5 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-173 | 63037-173-25 | Phenylephrine HCl | Phenylephrine HCl | 1 mg/10 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-174 | 63037-174-25 | Phenylephrine HCl | Phenylephrine HCl | .5 mg/5 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-155 | 63037-155-25 | Rocuronium Bromide | Rocuronium Bromide | 50 mg/5 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-156 | 63037-156-25 | Rocuronium Bromide | Rocuronium Bromide | 100 mg/10 mL | 2025-1 | valid | 2026-09-18 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-100 | 63037-100-05 | Fentanyl Citrate | 1000 ug/100 mL | 2025-1 | valid | 2026-10-26 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2500 ug/250 mL | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5200 | 26436-5200-1 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5641 | 26436-5641-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 20 ug/1 mL; 1 mg/1 mL | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5183 | 26436-5183-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5232 | 26436-5232-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 20 mg/1 mL; 5 ug/1 mL; .5 mg/1 mL | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5200 | 26436-5200-4 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5580 | 26436-5580-1 | Phenol | 50 mg/1 mL | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5473 | 26436-5473-3 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 20 mg/1 g; 80 mg/1 g | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 20 mg/1 g; 80 mg/1 g | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5429 | 26436-5429-2 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5601 | 26436-5601-5 | Phentolamine Mesylate; Papaverine Hydrochloride; Alprostadil | 4 mg/1 mL; 40 mg/1 mL; 30 ug/1 mL | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-6001 | 26436-6001-1 | Potassium Chloride | .2 meq/1 mL | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5465 | 26436-5465-3 | Prasterone; Estriol | 10 mg/1 g; 10 mg/1 g | 2025-1 | valid | 2026-10-26 | |
| Hybrid Pharma | 079665742 | 26436-5044 | 26436-5044-3 | Procaine Hydrochloride | 20 mg/1 mL | 2025-1 | valid | 2026-10-26 |